Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 11Thoracic 2Gastrointestinal 2Other 1

Conditions

Obesity 45Mucositis 29Neoplasms 23Sexual Dysfunction, Physiological 19Head and Neck Neoplasms 16Breast Neoplasms 16Opioid-Induced Constipation 12Dyspnea 11Constipation 11Pain 10Polycystic Ovary Syndrome 9Weight Loss 7Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Motor Activity 7Diabetes Mellitus 7Cardiovascular Diseases 6Xerostomia 5Stomatitis 5Radiation Injuries 5Overweight 5Sedentary Behavior 4Endometrial Neoplasms 4Diabetes Mellitus, Type 2 4Colorectal Neoplasms 4Bronchiolitis Obliterans Syndrome 4Sexuality 3Salivary Gland Neoplasms 3Hypertension 3Fatty Liver 3

Interventions

Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Deglutition Disorders × Other × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡